AISA 5203-L is one of four patented molecules which will be tested on a panel of healthy subjects aged 65-85 years, under the framework of a EU Capacities project (FP7) RISTOMED 222230
, as a nutraceutical food integrator aimed at lowering inflammatory and methabolic disease markers and increasing wellness (anti-stress effects).
results will be available in the summer of 2011; development and commercialization on the OTC nutraceutical market is envisioned for 2012.
Human chronic inflammatory diseases, degenerative diseases, tissue repair and stress treatment, i.e.: anti-aging treatment by nutrition for the elderly